Literature DB >> 32766741

Cholesterol profiles and incident cognitive decline among older adults: the Shanghai Aging Study.

Ding Ding1,2, Fen Zhou3,4,5, Yang Cao6, Xiaoniu Liang1,2, Wanqing Wu1,2, Zhenxu Xiao1,2, Qianhua Zhao1,2, Wei Deng3,4,5.   

Abstract

BACKGROUND: the association between cholesterol profiles and risk of cognitive decline among older adults was inconclusive.
OBJECTIVE: to examine the association between cholesterol profiles and risk of cognitive decline in older adults with or without vascular risk factors (VRFs) in the prospective phase of the Shanghai Aging Study.
DESIGN: a prospective community-based cohort study.
SETTING: Shanghai, China. PARTICIPANTS: we prospectively followed 1,556 dementia-free participants aged ≥60 years with a baseline cholesterol profile for 5.2 years on average. Participants with at least one of obesity, diabetes, hypertension, stroke, and coronary artery disease were categorised to the VRFs group, and those free of any VRFs were categorised to the non-VRFs group.
METHODS: total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol in serum were measured at baseline. At follow-up, consensus diagnosis of incident dementia and Alzheimer's disease (AD) were established based on medical, neurological, and neuropsychological examinations. Cox regression was used to assess the association between cholesterol and incident dementia/AD; multivariate linear regression was used to examine the relationship between cholesterol and an annual rate of Mini Mental State Examination (MMSE) score decline in participants with or without VRFs.
RESULTS: among VRFs-free participants, TC (HR 0.62, 95%CI 0.40-0.95) and LDL-C (HR 0.47, 95%CI 0.28-0.80) were inversely associated with incident dementia, LDL-C was inversely associated with incident AD (HR 0.50, 95%CI 0.28-0.90). A significant correlation was found between incremental TC (β = 0.08), LDL-C (β = 0.09), and a slower annual decline of MMSE score.
CONCLUSIONS: effect of cholesterol on cognitive decline may be modified by VRFs.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; cholesterol; dementia; incidence; older people; vascular

Mesh:

Substances:

Year:  2021        PMID: 32766741     DOI: 10.1093/ageing/afaa140

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  4 in total

1.  Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study.

Authors:  Anne M Murray; Yelena Slinin; David E Tupper; Sarah L Pederson; Cynthia Davey; David T Gilbertson; Paul Drawz; Ryan Mello; Allyson Hart; Kirsten L Johansen; Scott Reule; Rebecca Rossom; David S Knopman
Journal:  Am J Nephrol       Date:  2022-04-28       Impact factor: 4.605

Review 2.  Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol.

Authors:  Mingan Wu; Yingying Zhai; Xiaoyi Liang; Weichun Chen; Ruiyi Lin; Linlin Ma; Yi Huang; Di Zhao; Yong Liang; Wei Zhao; Jiansong Fang; Shuhuan Fang; Yunbo Chen; Qi Wang; Weirong Li
Journal:  Front Neurosci       Date:  2022-04-07       Impact factor: 5.152

3.  Association of occlusal support with type 2 diabetes: A community-based study.

Authors:  Dongxin Da; Suyu Ge; Hao Zhang; Xiaoli Zeng; Yiwei Jiang; Jin Yu; Huning Wang; Wanqing Wu; Zhenxu Xiao; Xiaoniu Liang; Ding Ding; Ying Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

4.  The Relationship Between Low-Density Lipoprotein Cholesterol and Progression of Mild Cognitive Impairment: The Influence of rs6859 in PVRL2.

Authors:  Qianyi Xiao; Jianxiong Xi; Ruru Wang; Qianhua Zhao; Xiaoniu Liang; Wanqing Wu; Li Zheng; Qihao Guo; Zhen Hong; Hua Fu; Ding Ding
Journal:  Front Genet       Date:  2022-02-21       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.